Description
LETROZOLE (Femara) is a selective, nonsteroidal aromatase inhibitor used to treat hormone receptor-positive breast cancer in postmenopausal women by reducing estrogen production in the body.
USES
- Breast cancer (for post-menopausal women).
GUARANTEE & EXPIRY DATE
100% original from various Russian pharmaceutical manufacturers. Product photo may vary. All packs are air tight sealed and expire up to 02.2027.
- Reduces risk of breast cancer recurrence and improves disease-free survival rates in postmenopausal women with hormone-sensitive cancers
- Provides alternative ovulation induction in women with PCOS, with higher live birth rates compared to clomiphene
- Well-established and included in major international cancer protocols.
Standard recommended dose: 2.5 mg taken orally once daily, with or without food. Duration depends on the indication; typically up to 5 years as adjuvant therapy or as directed for ovulation induction.
VIDEO
- Hot flashes, sweating, and flushing.
- Fatigue and lack of energy.
- Arthralgia (joint/muscle pain), bone pain, headache.
- Can cause dizziness and fatigue, so caution is advised when driving or operating machinery.
STORAGE
Store in dry place at room temperature. Do not exceed storage temperature higher than 25 degrees Celcius. Keep away from direct sunlight. Keep locked and away from children.
QUESTIONS?
Ask us any questions about Letrozole.